179 related articles for article (PubMed ID: 33803739)
1. Induction of AML Preleukemic Fusion Genes in HSPCs and DNA Damage Response in Preleukemic Fusion Gene Positive Samples.
Kosik P; Durdik M; Skorvaga M; Klimova D; Kochanova D; Cerna Z; Kubes M; Holop M; Belyaev I
Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33803739
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response and preleukemic fusion genes induced by ionizing radiation in umbilical cord blood hematopoietic stem cells.
Kosik P; Durdik M; Jakl L; Skorvaga M; Markova E; Vesela G; Vokalova L; Kolariková L; Horvathova E; Kozics K; Belyaev I
Sci Rep; 2020 Aug; 10(1):13722. PubMed ID: 32839487
[TBL] [Abstract][Full Text] [Related]
3. Backtracked analysis of preleukemic fusion genes and DNA repair foci in umbilical cord blood of children with acute leukemia.
Škorvaga M; Durdík M; Košík P; Marková E; Holop M; Kubeš M; Puškáčová J; Kolenová A; Belyaev I
Oncotarget; 2018 Apr; 9(27):19233-19244. PubMed ID: 29721197
[TBL] [Abstract][Full Text] [Related]
4. Preleukemic fusion genes typical for acute myeloid leukemia.
Klimová D; Styk J; Svoboda M; Humplíková S; Repiská V
Vnitr Lek; 2021; 67(E-5):9-12. PubMed ID: 35459386
[TBL] [Abstract][Full Text] [Related]
5. BCR/ABL preleukemic fusion gene in subpopulations of hematopoietic stem and progenitor cells from human UCB.
Jakl L; Skorvaga M; Beresova K; Kosik P; Durdik M; Jakubikova J; Holop M; Kubes M; Zastko L; Markova E; Beliaev I
Neoplasma; 2020 Jan; 67(1):158-163. PubMed ID: 31884803
[TBL] [Abstract][Full Text] [Related]
6. Preleukemic Fusion Genes Induced via Ionizing Radiation.
Kosik P; Skorvaga M; Belyaev I
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047553
[TBL] [Abstract][Full Text] [Related]
7. Microwaves from mobile phone induce reactive oxygen species but not DNA damage, preleukemic fusion genes and apoptosis in hematopoietic stem/progenitor cells.
Durdik M; Kosik P; Markova E; Somsedikova A; Gajdosechova B; Nikitina E; Horvathova E; Kozics K; Davis D; Belyaev I
Sci Rep; 2019 Nov; 9(1):16182. PubMed ID: 31700008
[TBL] [Abstract][Full Text] [Related]
8. Low numbers of pre-leukemic fusion genes are frequently present in umbilical cord blood without affecting DNA damage response.
Kosik P; Skorvaga M; Durdik M; Jakl L; Nikitina E; Markova E; Kozics K; Horvathova E; Belyaev I
Oncotarget; 2017 May; 8(22):35824-35834. PubMed ID: 28415763
[TBL] [Abstract][Full Text] [Related]
9. Incidence of preleukemic fusion genes in healthy subjects.
Kosik P; Skorvaga M; Belyaev I
Neoplasma; 2016; 63(5):659-72. PubMed ID: 27468869
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem/progenitor cells are less prone to undergo apoptosis than lymphocytes despite similar DNA damage response.
Durdik M; Kosik P; Kruzliakova J; Jakl L; Markova E; Belyaev I
Oncotarget; 2017 Jul; 8(30):48846-48853. PubMed ID: 28415626
[TBL] [Abstract][Full Text] [Related]
11. Probing altered hematopoietic progenitor cells of preleukemic dogs with JANUS fission neutrons.
Seed TM; Kaspar LV
Radiat Res; 1991 Oct; 128(1 Suppl):S81-6. PubMed ID: 1924754
[TBL] [Abstract][Full Text] [Related]
12. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML.
Barreyro L; Sampson AM; Hueneman K; Choi K; Christie S; Ramesh V; Wyder M; Wang D; Pujato M; Greis KD; Huang G; Starczynowski DT
iScience; 2024 Jun; 27(6):109809. PubMed ID: 38784013
[TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
[TBL] [Abstract][Full Text] [Related]
15. Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapse.
Ommen HB; Ostergaard M; Yan M; Braendstrup K; Zhang DE; Hokland P
Eur J Haematol; 2010 Feb; 84(2):128-32. PubMed ID: 19891700
[TBL] [Abstract][Full Text] [Related]
16. STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML.
Oancea C; Rüster B; Brill B; Roos J; Heinssmann M; Bug G; Mian AA; Guillen NA; Kornblau SM; Henschler R; Ruthardt M
Genes Cancer; 2014 Nov; 5(11-12):378-92. PubMed ID: 25568664
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract][Full Text] [Related]
18. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
[TBL] [Abstract][Full Text] [Related]
19. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
[TBL] [Abstract][Full Text] [Related]
20. [Related Factors Affecting Long-term Prognosis of AML Children with Positive RUNX1-RUNX1T1].
Teng GY; Qu WJ; Zhang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1767-1773. PubMed ID: 31839036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
